Legacy System Compensating Controls

The legacy system compensating controls requirement means you must protect any system or device that cannot be patched or upgraded with alternative safeguards that reduce exploitability and detect misuse, especially through network isolation and enhanced monitoring. You operationalize it by inventorying unpatchable assets, documenting risk acceptance, segmenting and restricting communications, and continuously monitoring the segment and hosts.

Key takeaways:

• Identify and label unpatchable/end-of-life assets, then place them under a documented compensating control plan.
• Make isolation real: restrict network paths, ports, identities, and management access, not just “put it on a VLAN.”
• Prove control effectiveness with retained evidence: diagrams, firewall rules, monitoring alerts, and risk sign-offs.

Legacy systems are not “temporary exceptions” in most healthcare environments; they are long-lived dependencies tied to clinical workflows, specialized applications, and end-of-life medical devices. HICP Practice 9.4 sets a clear expectation: if you cannot patch or upgrade, you still have to manage the risk with compensating controls, explicitly calling out network isolation and monitoring ¹.

For a Compliance Officer, CCO, or GRC lead, the win condition is straightforward: you can show (1) you know exactly which assets are unpatchable and why, (2) you reduced their attack surface with enforceable technical boundaries, and (3) you can detect and respond to suspicious activity involving those assets. Auditors rarely argue with the existence of legacy technology; they challenge ambiguity, missing ownership, and controls that are “documented” but not implemented.

This page gives requirement-level guidance you can execute quickly: scoping, control selection, evidence to retain, and exam questions to pre-answer. Where automation helps, platforms like Daydream can keep the inventory-to-evidence chain current across teams, but the core requirement remains operational discipline.

Regulatory text

Requirement (HICP Practice 9.4): “Implement compensating controls for legacy systems and devices that cannot be patched or upgraded, including network isolation and monitoring.” ¹

What the operator must do

If an asset cannot receive security updates, you must:

1. Acknowledge it as a known condition (not an undocumented exception).
2. Reduce exposure through compensating controls, with network isolation as a primary mechanism.
3. Increase detection through monitoring appropriate to the risk and clinical impact.
   This is not optional hardening; it is the alternative control path that replaces patching/upgrading when patching is infeasible ¹.

Plain-English interpretation

Patching is the default risk treatment. When patching is impossible, you still owe the organization a defensible security posture. “Compensating controls” means layered safeguards that make exploitation harder, contain blast radius, and help you detect and respond quickly if compromise occurs. For healthcare, that commonly includes segmenting medical devices and legacy servers, restricting who/what can talk to them, and watching that traffic and activity closely ¹.

Who it applies to

Entity types

• Healthcare organizations (provider organizations, payers, integrated delivery networks) that operate clinical and enterprise systems.
• Health IT vendors that host, manage, or connect to customer environments where unpatchable components exist ¹.

Operational context

• End-of-life operating systems supporting clinical apps, lab systems, imaging, or middleware.
• Medical devices with manufacturer constraints, validation requirements, or unsupported firmware.
• Embedded/OT-like systems that are safety- or uptime-sensitive.
• Third-party managed appliances where you cannot apply updates directly, but you can enforce network and access constraints around them.

If you rely on third parties (device manufacturers, managed service providers, hosted EHR modules), you still need compensating controls on the parts you operate and clear contractual responsibility for the parts you do not.

What you actually need to do (step-by-step)

1) Build a defensible legacy/unpatchable asset register

Minimum fields to capture:

• Asset identifier, owner, location, function (clinical/administrative)
• Why it cannot be patched/upgraded (technical constraint, vendor restriction, validation requirement)
• Connectivity map: inbound/outbound protocols, dependencies, remote access paths
• Data sensitivity and operational criticality
• Existing controls and gaps
  This is the backbone for audits and for prioritizing isolation and monitoring work.

Practical tip: If your CMDB is incomplete, start with a targeted discovery for known legacy OS versions and medical device subnets, then reconcile with clinical engineering and IT networking.

2) Perform a focused risk assessment and document the decision

For each unpatchable asset class, document:

• Likely attack paths (phishing to lateral movement, exposed services, third-party remote access)
• Business/clinical impact of downtime or tampering
• Minimum compensating control set required
• Residual risk and who accepts it
  Keep this short and operational. Auditors want to see that risk treatment choices are explicit and owned.

3) Implement network isolation that is enforceable

HICP explicitly calls out isolation ¹. Make it concrete:

Isolation design checklist

• Put legacy systems/medical devices into dedicated network segments.
• Default to deny-by-default between segments; allow only required flows.
• Limit communications to specific peers, ports, and protocols (document each allow rule to a business need).
• Prevent direct internet access unless explicitly required; if required, tightly control and monitor egress.
• Separate management interfaces from production interfaces.
• Control remote access with strong authentication and jump hosts/bastions where feasible.

Common “looks isolated but isn’t” traps

• A VLAN with broad inter-VLAN routing still allows lateral movement.
• “Any-any” firewall rules for troubleshooting that never get removed.
• Flat Wi-Fi or shared switch infrastructure bridging clinical devices and corporate endpoints.

4) Add application-level and host-level compensating controls

HICP’s summary emphasizes application-level controls alongside isolation and monitoring ¹. Depending on asset type, implement:

• Strict local account management (remove default accounts where possible)
• Application allowlisting where feasible
• Disable unused services and ports
• Restrict admin tools and scripting engines on legacy Windows hosts where supported
• Encrypt sensitive data in transit via gateways/proxies when the endpoint cannot support modern crypto

Where host agents are impossible (common with medical devices), shift controls “one hop away” to gateways, NAC, firewalls, and passive monitoring.

5) Implement enhanced monitoring that can prove detection

HICP explicitly calls out monitoring ¹. Monitoring should match the environment:

• Centralize logs you can get (OS logs, application logs, firewall logs, VPN/jump host logs).
• Monitor network traffic for unusual destinations, protocols, and volumes from legacy segments.
• Alert on new inbound connections to legacy segments, policy violations, and repeated authentication failures.
• Tune to reduce noise; document what “actionable” means and who responds.

Operational requirement: monitoring without alert triage and ownership fails audits. Define an on-call path or ticketing workflow for alerts involving legacy segments.

6) Control and test third-party access paths

Legacy environments often depend on manufacturer/service-provider remote support. Enforce:

• Time-bound access approvals
• Unique accounts (no shared vendor accounts when avoidable)
• Session logging where possible
• Network constraints so remote access can only reach specific devices/services

7) Validate effectiveness and keep it current

You need a repeatable cadence:

• Review isolation rules when clinical workflows change.
• Reconfirm “unpatchable” status with manufacturers and internal engineering.
• Track compensating controls as control objectives with measurable checks (rule review, alert review, access review).

Where Daydream fits: Daydream can help tie asset inventory, third-party relationships, control ownership, and evidence collection into one workflow so your “legacy exception” doesn’t become a quarterly scramble.

Required evidence and artifacts to retain

Auditors typically ask for proof of both design and operation. Retain:

• Legacy/unpatchable asset register with ownership and rationale
• Network diagrams showing segmentation boundaries for legacy/medical device zones
• Firewall/ACL/NAC policy exports or screenshots with change history
• Approved exception or risk acceptance records for unpatchable status and residual risk
• Monitoring configuration evidence: log sources, alert rules, escalation paths
• Samples of monitoring outputs: alerts, tickets, investigations, and closure notes
• Third-party access records: approvals, session logs (if available), account lists
• Change management records for segmentation and access rule changes

Common exam/audit questions and hangups

Questions you should be ready for

• “Which assets cannot be patched, and how do you know?”
• “Show me how the legacy subnet is isolated. What traffic is allowed and why?”
• “How do you detect compromise of a medical device that can’t run an agent?”
• “Who reviews alerts, and what is the response process?”
• “How do you govern third-party remote support into these segments?”

Hangups

• No single owner (IT says clinical engineering owns it; clinical says IT owns the network).
• “We segment” but cannot produce the rule set or rationale.
• Monitoring exists but nobody can show tickets or response actions.

Frequent implementation mistakes and how to avoid them

1. Mistake: Treating compensating controls as a paper exception.
   Fix: Require a minimum technical baseline (segmentation + monitoring) before risk acceptance is approved.

2. Mistake: Over-permissive rules to keep operations calm.
   Fix: Convert “temporary” allow rules into time-bound changes with expiration, then review with app owners.

3. Mistake: No visibility into third-party access.
   Fix: Route support through controlled paths (jump host/VPN with logging) and document approvals.

4. Mistake: One-size monitoring.
   Fix: Define different monitoring profiles for legacy servers vs. unmanaged devices; prove someone reviews the signals.

Enforcement context and risk implications

No public enforcement cases were provided in the source catalog for this requirement. Practically, the risk is not abstract: unpatchable systems create predictable footholds for attackers, and weak segmentation turns a single vulnerable device into organization-wide exposure. Your audit posture improves materially when you can show containment boundaries and demonstrated monitoring around those boundaries ¹.

Practical 30/60/90-day execution plan

First 30 days (stabilize and scope)

• Name an accountable owner for legacy compensating controls (IT security with clinical engineering partnership).
• Produce an initial unpatchable asset register from CMDB + discovery + stakeholder validation.
• Identify highest-risk zones (internet-adjacent paths, shared segments with corporate endpoints, broad third-party access).
• Freeze expansion: require security review before any new legacy device/system goes live on shared networks.

Next 60 days (implement the minimum defensible baseline)

• Create dedicated segments for priority legacy/medical device groups.
• Implement deny-by-default inter-segment rules; document business justification for each exception.
• Stand up monitoring for those segments: firewall logs + network telemetry + ticketing workflow.
• Put third-party remote access behind a controlled path with approvals and logging where feasible.

By 90 days (prove operation and make it repeatable)

• Run a tabletop or operational test: simulate suspicious traffic from a legacy segment and validate detection-to-ticket-to-response.
• Complete risk acceptance packages for assets that remain unpatchable, including compensating control mapping.
• Establish ongoing governance: change control triggers, periodic rule reviews, and recurring evidence capture.
• If you use Daydream, configure recurring evidence requests to asset owners and network/security teams so audits pull from live artifacts instead of email threads.

Frequently Asked Questions

What counts as a “legacy system” for this requirement?

Any system or device that cannot be patched or upgraded in a timely way due to technical, vendor, or validation constraints qualifies. The key is the constraint, not the age.

Is putting devices on a separate VLAN enough?

Usually no. VLANs help organize traffic, but auditors will look for enforceable restrictions like firewall/ACL rules and explicit allowlists of required communications.

How do we monitor medical devices that can’t run an endpoint agent?

Shift monitoring to the network and supporting infrastructure: segment-level firewall logs, passive network monitoring, and strict alerting on new or abnormal connections to and from the device subnet.

What if the manufacturer requires broad network access for support?

Treat that as a risk and constrain it: route access through controlled remote access with approvals, limit reachable systems, and record sessions where possible. Keep documentation showing why the access is needed and what boundaries you enforced.

Do we need formal risk acceptance for every single unpatchable asset?

You need a defensible decision record. For large fleets, group identical assets into classes with the same constraint and compensating control set, then document exceptions at the class level plus any outliers.

How do we show auditors the controls are operating, not just designed?

Provide evidence of monitoring outputs and action: recent alerts, tickets, investigations, and rule review/change records tied to the legacy segments and assets.

Footnotes

1. HICP 2023 - 405(d) Health Industry Cybersecurity Practices